Discover the role of Sipuleucel-T immunotherapy in treating castration-resistant prostate cancer, a significant advancement in prostate cancer therapy.
SIPULEUCEL-T IMMUNOTHERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
A unique clinical trial identification number generated by Mary Crowley Cancer Research.
Glossary
Condition:
The cancer type reflective of your diagnosis. If you do not see your cancer type, it may be under a different name, type in the box to search for your specific condition.
Glossary
Target:
A term used to describe certain genes, proteins, and other molecules that are involved in the growth, spread, and survival of cancer cells and may be used as targets for cancer treatment.
Glossary
Drug Classification:
A group of medications and other compounds that have similar chemical structures, similar modes/mechanisms of action, and/or are used to treat similar diseases.
Glossary
NCT:
A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
Glossary
Publications:
Whether a manuscript is published by the pharmaceutical sponsor relating to that specific clinical trial.
